News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merrimack Pharmaceuticals Inc. to Present Preclinical Data at the 24th EORTC-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics



11/1/2012 7:30:14 AM

CAMBRIDGE, Mass., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) announced today that preclinical data on two novel cancer compounds will be presented at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland November 6 – 9, 2012.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES